In case you haven’t heard of this event yet, the World Precision Medicine Congress (WPMC) is an industry gathering in London, bringing together over 600 decision makers, influencers and innovators from across academia, biotech and the pharmaceutical industry.

What’s so special? The awesome team at Terrapinn (the congress organisers) is offering a full pass for free to one lucky Labiotech reader. The pass also includes access to two other joint conferences. More details on that below.

Hear the industry disruptors: Adam Blatt, Global Head of Genomics at AstraZeneca; Susan Solomon, CEO and Co-Founder of the New York Stem Cell Foundation; and more from GSK, Duke University, Human Longevity Project, Novartis and others.

The programme boasts keynote presentations from influential thought leaders in the industry, there are 6 focused tracks to chose from and if that wasn’t enough it’s co-located with the World Advanced Therapies & Regenerative Medicine Congress and World Cord Blood Congress

For more details check out the brochure here!

More on the ticket giveaway:

The World Precision Medicine Congress is partnering with Labiotech to offer a free ticket to attend the conference taking place on 17-19 May in London!

What you’ll get:

  • Access to the World Precision Medicine Congress and co-located conferences: the World Advanced Therapies & Regenerative Medicine Congress and the World Cord Blood Congress
  • Access to the exhibition part of the congress
  • And of course: free refreshments and lunches, plus free access to the networking functions

How to take part in the prize draw?

  • Just drop use your email above (you’ll need a company email address)
  • The prize draw closes at 23:59 on 7 May 2017 (Ts&Cs accessible here )
  • The winner will be randomly selected and contacted on 8 May

We wish you the best of luck!

P.S. We are planning on teaming up with a few more events, so we can have more giveaways for our awesome readers (that’s you!) – stay tuned for more! – What’s your favourite event, whom should we partner with? – Send us a quick email or let us know in the comments.


Image from Corepics VOF / shutterstock.com

Previous post

New Immuno-oncology Biotech Gets a €20M Series A Funding Boost

Next post

New Public-Private French Collaboration will Develop CAR-Tregs